Loading cancer entity…
Loading cancer entity…
Clinical trials
452 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06169735 | Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation | terminated | Phase 4 | 417 | University of Alabama at BirminghamOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT02032784 | Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding | terminated | Phase 4 | 33 | AdventHealthOTHER | 1 | Jul 16, 2020 | clinicaltrials |
Showing 1–2 of 2 studies
Data updated 22 days agoSource updated May 6, 2026source: clinicaltrials